https://www.selleckchem.com/pr....oducts/avotaciclib-t
The purpose of this study was to examine the factors associated with disparities in overall survival (OS) by race in pediatric diffuse large B-cell lymphoma (DLBCL) patients. We evaluated clinical features and survival among patients ≤21years of age diagnosed with stage I-IV DLBCL from 2004 to 2014 from the National Cancer Database (NCD using a multivariable Cox proportional hazards model. Among 1386 pediatric patients with DLBCL, 1023 patients met eligibility criteria. In unadjusted analysis, Black patients had a
Like
Comment
Share
